Nose Spray Vaccines Could Quash COVID Virus Variants
Three nasal spritzes, now in advanced trials, could trigger stronger immunity than shots in the arm
Related Articles
Revolutionizing Medicine Through Lymphatic Biology: The Story of Rho Bio | Yale Ventures
For decades, the lymphatic vascular system—a critical network that drains cellular waste and maintains immune balance—has been overlooked in biomedical research. Enter Rho Bio, a…
A B cell screen against endogenous retroviruses identifies glycan-reactive IgM that recognizes a broad array of enveloped viruses
Profiling of ERV-reactive B-1 cells in mice reveals natural antibodies against terminal N-acetylglucosamine on multiple viral envelope proteins.
Hirschhausen und der lange Schatten von Corona – hier anschauen
Corona hat Spuren hinterlassen, Leben verändert – und hunderttausende Menschen dauerhaft krank gemacht. Deutschlands bekanntester Arzt, Eckart von Hirschhausen, begleitet einige der Betroffenen seit Jahren.…
A B cell screen against endogenous retroviruses identifies glycan-reactive IgM that recognizes a broad array of enveloped viruses
Profiling of ERV-reactive B-1 cells in mice reveals natural antibodies against terminal N-acetylglucosamine on multiple viral envelope proteins.
Antibodies that keep ancient viral DNA in check may inform new
B-1 immune cells can recognize all sorts of viruses, Yale researchers find. Mimicking them may enable a pan-virus treatment that can address many virus types.
A B cell screen against endogenous retroviruses identifies glycan-reactive IgM that recognizes a broad array of enveloped viruses
Profiling of ERV-reactive B-1 cells in mice reveals natural antibodies against terminal N-acetylglucosamine on multiple viral envelope proteins.
Unadjuvanted intranasal spike vaccine elicits protective mucosal immunity against sarbecoviruses
An intranasal spike protein boost generates broadly protective anti-sarbecovirus mucosal immunity in animals.
Intranasal hemagglutinin protein boosters induce robust mucosal immunity and cross-protection against influenza A viral challenge
Licensed parenteral influenza vaccines induce systemic antibody responses and alleviate disease severity but do not efficiently prevent viral entry and transmission due to the lack…
SARS-CoV-2 ORF6 disturbs nucleocytoplasmic trafficking to advance the viral replication
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the virus responsible for the coronavirus disease 2019 pandemic. ORF6 is known to antagonize the interferon signaling…
ABO blood group and link to COVID-19: A comprehensive review of the reported associations and their possible underlying mechanisms
ABO blood group is long known to be an influencing factor for the susceptibility to infectious diseases, and many studies have been describing associations between…